Suven Pharma
  • 03 July, 2024 Ruchit Thakur

Suven Pharma

Suven Pharma appears to be a good long-term investment, as its stock has reached an all-time high and is climbing.

Please review the Suven Pharma weekly chart and comprehend its structure. Suven Pharma, as seen in the chart, is an excellent buy in the 750-760 zone, and it has performed admirably thus far, with enormous upside potential.

Please review the Suven Pharma weekly chart. Following its breakout from the 750-760 range, the stock is trading above horizontal resistance and continues to advance. As shown in the graph, Suven Pharma is currently in high demand in the 760 price range. The projected gain is 950-980, as seen in the chart below. 

  • Suven Pharma is a fantastic long-term investment opportunity because it has had a reasonable breakout around the 750-760 level and is currently rising.
  • Suven Pharma appears to be in a strong position on the chart, with potential for further gains to 950 and 980.
  • As of today, 750-760 represents the finest opportunity to acquire this company because the risk-to-reward ratio was optimal for a cash transaction.
  • According to the chart, one broke out of the ascending triangle pattern, with a target range of 950 to 980.

 

Please see the Suven Pharma weekly chart for reference. The weekly chart shows horizontal resistance and breakout, as well as demand in the 750-760 zone, and the stock is rising in response to the strong demand in that region.

Please take note of the horizontal resistance and its breach, which resulted in the stock reaching a new all-time high today, signaling a great buying opportunity at the current market price. So far, the stock has followed the chart's upward trend, reaching 950 and 980, respectively, which meets the pattern's goal.

Suven Pharma emerged from the rising triangle, and the pattern's latest target ranges from 950 to 980. The ascending triangle is a chart pattern used in technical analysis. Price movements result in a horizontal line at the swing highs and a rising trend line at the swing low. The two lines make a triangle.

Investors may seek a long-term purchase opportunity in the 750-760 range and profit on any dips that occur as the stock is in high demand, perhaps leading to a recovery to the 950 and 980 levels, showing a favorable risk-reward ratio. Use every dip to buy this stock since it has a strong upside potential, and every dip is an opportunity to invest.

Investors could buy the stock with cash over time and put a stop loss at 690 to accomplish price goals ranging from 950 to 980.

As a trader or investor, I usually look for a VCP pattern, which is a Volatility Contraction Pattern in which price volatility contracts before a major rise, so that the stock or instrument can obtain good volume and enormous upside with a rapid rise and target hit. To learn more about VCP patterns, please visit our website and download our app. We also describe how to identify such patterns with high accuracy. 

The Suven Pharma weekly chart shows both support and resistance. The spot chart illustrates each level.

Suven Pharma

Support

Resistance

Level 1

690

950

Level 2 

680

980

 

Company Profile: Suven has established a core competency in cyanation and heterocyclic chemistry, including pyrimidines, quinolones, thiazoles, and imidazoles, as well as demonstrated proficiency in carbohydrate and chiral chemistry, including tetrahydrofurans, amino acids, and sulfoxides, and has dabbled in all chemistry except fluorination and phosgenation on a gram to multi-ton scale.

Suven Pharmaceuticals Limited, a Telangana-based company founded on November 6, 2018 under the Companies Act of 2013, was formed as a Resulting Company as part of the Scheme of Arrangement (Demerger) between Suven Life Sciences Limited and Suven Pharmaceuticals Limited. 
 

Disclaimer: This expression is commonly used to convey that the content or material being seen is solely for educational reasons and should not be utilized for anything else. This example is just for educational purposes and should not be used commercially.